Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Scott Mendel, Richard Slansky

Premium

Scott Mendel has been named CFO at GenMark Diagnostics, the firm said this week.

Mendel joins GenMark from Active Network, where he held the same position for four years. Prior to Active Network, he worked at GE for more than 20 years, most recently serving as CFO of the company's Healthcare IT division.

Mendel's appointment as CFO is effective May 13. He replaces Richard Slansky, who has left the company for personal reasons.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.